Compare Bio Protocol (BIO) vs Radiant Capital (RDNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Radiant Capital — how do they compare? Bio Protocol trades at Rp516.1 (market cap Rp1,15T, Rp260,42M 24h volume), while Radiant Capital trades at Rp55.8 (market cap Rp128,13M, Rp581,09M 24h volume). The key difference: Bio Protocol is far larger — about 8975.3× Radiant Capital's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 1,4B / 1,5B RDNT (93%) for Radiant Capital. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Radiant Capital for 18 Days on average.
| BIO | RDNT | |
|---|---|---|
Market Cap | Rp1,15T | Rp128,13M |
Volume (24h) | Rp260,42M | Rp581,09M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 1,4B / 1,5B RDNT (93%) |
Typical Hold Time | 16 Days | 18 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Radiant Capital (RDNT) shows a market cap of Rp128.13M with 93% of its 1.5M max supply in circulation. The token demonstrates strong network activity with an average hold time of 18 days, indicating healthy user engagement. Recent protocol developments focus on cross-chain lending expansion and liquidity optimization, though specific technical metrics require verification from blockchain explorers.
Overall outlook remains cautiously optimistic given the project's established DeFi lending infrastructure. Key opportunities include growing cross-chain interoperability adoption, while major risks involve typical crypto volatility and regulatory uncertainty in the rapidly evolving DeFi landscape.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Radiant Capital
Radiant Capital is a DeFi protocol that tackles capital fragmentation by creating a unified omnichain money market. It enables users to easily deposit and borrow assets across multiple blockchains, improving efficiency and user experience in the DeFi ecosystem.
Read more on RDNT →
